Articles

Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia

Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty;Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg
Department of Orthopedic Surgery, University of Duesseldorf, Medical Faculty, Germany
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty
Vol. 103 No. 9 (2018): September, 2018 https://doi.org/10.3324/haematol.2017.186734